Session Details

[26G-pm]Cancer-2

Sat. Mar 26, 2022 3:42 PM - 4:54 PM JST
Sat. Mar 26, 2022 6:42 AM - 7:54 AM UTC
[Room G] Exhibition Room 212 Bldg. 2: 1F
Chair: Tomoka Takatani-Nakase

[26G-pm12]Ferroptosis sensitivity of SLUG-transduced EMT cells

○Yu Kato1, Yukari Fukazawa1, Shingo Kondo1, Yoshikazu Sugimoto1 (1. Div. Chemother., Facul. Pharm., Keio Univ.)

[26G-pm13]Integrated analysis of resistance mechanisms to CHK1 and WEE1 inhibitors

○Shingo Kondo1, Ken Okuda1, Riho Saito1, Yu Kato1, Yoshikazu Sugimoto1 (1. Div. Chemother., Facul. Pharm., Keio Univ.)

[26G-pm14]SOX10 regulates melanoma immunogenicity through an IRF4-IRF1 axis.

○Satoru Yokoyama1, Atsushi Takahashi1, Ryota Kikuchi1, Soshi Nishibu1, Yue Zhou1, Yoshihiro Hayakawa2, Hiroaki Sakurai1 (1. Grad. Sch. Pharm. Sci., Univ. Toyama, 2. Inst. Nat. Med., Univ. Toyama)

[26G-pm15]Increased myeloid cells in cancer exacerbate anaphylaxis to anti-PD-L1 antibodies.

○Takahiro Arai1, Tomomi Kokubo1, Ruihen Tang1, Hirohito Abo1, Jotaro Hirakawa1, Hidetaka Akita1,2, Hiroto Kawashima1, Akihiro Hisaka1, Hiroto Hatakeyama1 (1. Grad. Sch. Pharm. Sci., Chiba Univ., 2. Grad. Sch. Pharm. Sci., Tohoku Univ.)

[26G-pm16S]pH-low insertion peptide detects acidic environment in metastatic niche

○Toma Matsui1, Yuki Toda1, Ryota Nakai1, Aoi Yokogawa1, Rina Itagaki1, Shigekuni Hosogi1, Eishi Ashihara1 (1. Kyoto Pharm. Univ.)

[26G-pm17S]Mechanism of the nuclear receptor PXR-mediated suppression of epithelial-mesenchymal transition of liver cancer cells

○Takumi Sato1, Ryota Shizu1,2, Ryonosuke Baba2, Mai Ishimura2, Takuomi Hosaka1,2, Takamitsu Sasaki2, Yuichiro Kanno1,2, Kouichi Yoshinari1,2 (1. Grad. Sch. Integ. Pharm. Nutr. Sci., Univ of Shizuoka, 2. Sch. Pharm. Sci., Univ of Shizuoka)